Henry Schein, Inc. supplies health care products and services to office-based dental and medical practitioners worldwide. It operates through three segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. The company serves dental practices, laboratories, physician practices, ambulatory surgery centers, government and institutional clinics, home health providers, and other alternate care clinics. Founded in 1932, it is headquartered in Melville, New York, and has a strategic partnership with GoTu Technology to address staffing challenges in dental practices.
Henry Schein Names Emmanuel Caprais CFO as Ronald South Steps Down
Henry Schein, Inc. announced that Emmanuel Caprais, former Senior Vice President and Chief Financial Officer of ITT, Inc., will become the Company's Senior Vice President and Chief Financial Officer effective November 4, 2026. Caprais will join the Henry Schein Leadership Team and report to Chief Executive Officer Frederick M. Lowery, and will initially serve as Senior Financial Advisor beginning October 12, 2026, to support a structured transition. Ronald N. South, who has spent 18 years with the Company and the past four years as CFO, will transition into a senior advisory role effective November 4, 2026. Caprais brings more than 25 years of global leadership experience, having served as CFO of ITT from 2020 until May 2026, with earlier finance roles at Magneti Marelli and Valeo. In addition to the CFO transition, Henry Schein said it anticipates adding two positions to its leadership team: a Chief Strategy and Transformation Officer and a new technology leadership position encompassing AI implementation, data, and broader technology needs.
HSIC · Capital · Neutral Henry Schein names Emmanuel Caprais as new CFO, replacing Ronald South, plus plans to add strategy and technology leadership roles.
Henry Schein Extends Credit Facility to $1.25 Billion Through 2031
Henry Schein amended and restated its revolving credit facility, increasing total commitments to $1.25 billion and extending the termination date to September 19, 2031. The medical products distributor's shares traded at $86.37, up 0.98% over one day and 1.80% over seven days, though the 30-day return slipped 3.52% while the year-to-date return stands at 12.43%. The 1-year total shareholder return of 30.74% suggests investors have read the upgraded facility and a recent guidance raise as supportive of both growth plans and perceived risk. The most followed valuation narrative pegs fair value at $98.19, above the latest close, with the company expecting more than 50% of non-GAAP operating income to come from high-margin businesses such as Specialty Products, Technology, and private-label offerings. Risks to that case include scanner pricing pressure eroding equipment margins faster than expected or multi-year analyst forecasts proving too optimistic.
HSIC · Capital · Positive Henry Schein amended and restated its revolving credit facility, boosting total commitments to $1.25 billion and extending maturity to 2031, strengthening its financing position.
Henry Schein Raises 2026 Sales Growth Guidance After Q2 Revenue Hits $3.46 Billion
Henry Schein raised its 2026 total sales growth guidance following second-quarter results that showed revenue of $3,458 million and net income of $94 million, with higher earnings per share from continuing operations compared to a year earlier. The upgraded outlook signals management’s increased confidence in operating initiatives and demand trends, reinforcing the investment narrative around margin expansion and digital growth. The company also formed a new Henry Schein Leadership Team and is integrating its global supply chain with distribution, moves that sit alongside the raised guidance as key factors for cost efficiency and value creation. However, risks remain if leadership transitions or supply chain integration face delays, potentially affecting the pace at which higher-margin segments and cost savings materialize. Henry Schein’s long-term projections target $14.9 billion in revenue and $653.3 million in earnings by 2029, implying 3.8% annual revenue growth and a $258 million increase from current earnings of $395 million.
HSIC · Capital · Positive Raised 2026 sales growth guidance and reported Q2 revenue of $3.46B with higher EPS, signaling confidence in operations and demand.
Henry Schein second-quarter profit rises to $94 million
Henry Schein Inc. reported a second-quarter profit of $94 million, or $0.82 per share, up from $86 million, or $0.70 per share, a year earlier. Excluding items, adjusted earnings were $145 million, or $1.27 per share. Revenue rose 6.7% to $3.458 billion from $3.240 billion. The company issued full-year earnings per share guidance of $5.29 to $5.39 and expects full-year revenue growth of 4.5% to 5.5%.
StockStory Flags Nature's Sunshine, Delta, and Henry Schein as Profitable but Risky
StockStory identifies Nature's Sunshine, Delta Air Lines, and Henry Schein as profitable companies that may face sustainability challenges. Nature's Sunshine, with a trailing 12-month GAAP operating margin of 5.7% and annual revenue growth of 5.3% over three years, is seen as disadvantaged by its $489.8 million revenue base and below-industry-average margins. Delta Air Lines, carrying an 8.1% operating margin, shows sluggish revenue passenger mile trends and shrinking returns on capital, with its stock at $86.36 per share. Henry Schein, at a 4.9% operating margin, has underperforming organic revenue and estimated sales growth of just 3.7% for the next 12 months, with its stock at $88.27.
GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide
GoTu Technology and Henry Schein have announced a strategic partnership to help dental practices address staffing shortages. Through the collaboration, dental practices will gain expanded access to GoTu's platform, which connects offices with qualified dental hygienists, dental assistants, and associate dentists for temporary and permanent roles. GoTu will become part of Henry Schein Dental Recruitment Services, a division of Henry Schein Financial Enterprises, a wholly-owned subsidiary of Henry Schein. The partnership combines GoTu's workforce technology with Henry Schein's extensive customer network to deliver flexible staffing solutions. GoTu has filled more than 500,000 shifts nationwide, and Henry Schein serves more than 1 million customers globally.
Dental Equipment Stocks Beat Q1 Revenue Estimates but Shares Decline
The four dental equipment and technology stocks tracked by StockStory reported strong first-quarter results, with aggregate revenues beating analysts' consensus estimates by 3% while next-quarter revenue guidance was in line. Dentsply Sirona posted flat revenue of $880 million, exceeding expectations by 4.8%, but its stock fell 10% since reporting. Envista delivered the fastest revenue growth among its peers at 14.4% to $705.5 million, yet shares declined 6.7%. Henry Schein, the weakest performer against estimates, saw revenue rise 6.3% to $3.37 billion and its stock gained 11.2%. Align Technology reported a 6.2% revenue increase to $1.04 billion, beating estimates, but its stock dropped 6.3%. On average, share prices across the group are down 2.9% since the latest earnings results.
United States